PASITHEA THERAPEUTICS CORP. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate
PASITHEA THERAPEUTICS CORP. (KTTA) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate of 40.40% for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate · last filed 2022-11-14
- 2022-09-30: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 9 month 40.40%.
- 2022-06-30: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 6 month 40.40%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 6 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 9 month |
|---|---|---|
| 2022-09-30 | 40.40% 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 40.40% 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |